Disruption of splicing in the PTEN gene, an important tumor suppressive phosphatase, by PNA was published by Wancewicz et al. [131] as a simple way to evaluate semi-quantitatively the efficiency of anti-PTEN PNA cross-linked with peptides for targeted delivery to various tissues. This evidence concerns the gene PTEN and neoplasm.